GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Evome Medical Technologies Inc (TSXV:EVMT) » Definitions » Gross-Profit-to-Asset %

Evome Medical Technologies (TSXV:EVMT) Gross-Profit-to-Asset % : 38.83% (As of Sep. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Evome Medical Technologies Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Evome Medical Technologies's annualized Gross Profit for the quarter that ended in Sep. 2024 was C$14.25 Mil. Evome Medical Technologies's average Total Assets over the quarter that ended in Sep. 2024 was C$36.69 Mil. Therefore, Evome Medical Technologies's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2024 was 38.83%.


Evome Medical Technologies Gross-Profit-to-Asset % Historical Data

The historical data trend for Evome Medical Technologies's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evome Medical Technologies Gross-Profit-to-Asset % Chart

Evome Medical Technologies Annual Data
Trend Dec14 Feb15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.35 3.13 52.16 21.36 49.56

Evome Medical Technologies Quarterly Data
Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 42.12 38.14 34.70 32.96 38.83

Competitive Comparison of Evome Medical Technologies's Gross-Profit-to-Asset %

For the Medical Devices subindustry, Evome Medical Technologies's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Evome Medical Technologies's Gross-Profit-to-Asset % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Evome Medical Technologies's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Evome Medical Technologies's Gross-Profit-to-Asset % falls into.



Evome Medical Technologies Gross-Profit-to-Asset % Calculation

Evome Medical Technologies's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Feb. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=22.533/( (42.682+48.257)/ 2 )
=22.533/45.4695
=49.56 %

Evome Medical Technologies's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Sep. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=14.248/( (38.262+35.126)/ 2 )
=14.248/36.694
=38.83 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Sep. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Evome Medical Technologies Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Evome Medical Technologies's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Evome Medical Technologies Business Description

Traded in Other Exchanges
Address
49 Natcon Drive, Shirley, New York, NY, USA, 11967
Evome Medical Technologies Inc is a medical device company. It is focused on human performance and rehabilitative solutions.

Evome Medical Technologies Headlines